AirSeal CardioVascular Inc.

AirSeal CardioVascular Inc.

Private
Saint Louis, MichiganHealthcare & Life Scienceshttps://www.airsealcv.com

Last Round

VC Round

Apr 17, 2025

Total Funding Raised

$676,000

Company Overview

AirSeal CardioVascular Inc. is a medical diagnostics company that developed a patented blood test designed to detect peripheral artery disease (PAD) and other cardiovascular conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

PAD diagnosisperipheral artery diseasecardiovascular diagnosticsimmunoassayPADGuard™cardiovascular biomarkercFASin vitro diagnosticsIVDmedical diagnosticsdiagnostic testcirculating fatty acid synthaseAnkle-brachial IndexABIclinical trial supportSmall Business Innovation ResearchSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AirSeal CardioVascular Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AirSeal CardioVascular Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 17, 2025
GrantNov 21, 2024
GrantNov 5, 2024
GrantOct 1, 2023
Pre SeedApr 23, 2023

AirSeal CardioVascular Inc. Investors

Notable investors and investment history

AirSeal CardioVascular Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AirSeal CardioVascular Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AirSeal CardioVascular Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint Louis, Michigan
Employee Range2
Year Founded2022
Last FundingApr 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.